Cardica Inc. (NASDAQ:DXTR) had its price objective cut by investment analysts at Wedbush to $5.00 in a report issued on Tuesday. The brokerage presently has an “outperform” rating on the stock. Wedbush’s target price indicates a potential upside of 222.58% from the stock’s previous close.

Separately, Zacks Investment Research upgraded Cardica from a “sell” rating to a “hold” rating in a research note on Tuesday, October 18th.

Shares of Cardica (NASDAQ:DXTR) opened at 1.55 on Tuesday. The firm’s market capitalization is $13.84 million. The firm has a 50-day moving average of $1.82 and a 200-day moving average of $2.26. Cardica has a one year low of $1.09 and a one year high of $4.30.

Cardica (NASDAQ:DXTR) last announced its earnings results on Monday, November 7th. The company reported ($0.44) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.48) by $0.04. On average, equities analysts predict that Cardica will post ($1.53) earnings per share for the current fiscal year.

About Cardica

Dextera Surgical Inc, formerly Cardica, Inc, is focused on the commercialization and development of microcutter product line intended for use by surgeons. The Company is engaged in commercializing and developing MicroCutter XCHANGE 30 based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

5 Day Chart for NASDAQ:DXTR

Receive News & Stock Ratings for Cardica Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardica Inc. and related stocks with our FREE daily email newsletter.